| Financial Year |
March 31 2023 |
| Monetary Funds |
1,116,573,674.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,518,564.96 |
| Accounts Receivable |
2,798,283,693.28 |
| Advances to Suppliers |
1,519,723,206.26 |
| Other Receivables |
307,214,812.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,596,666.67 |
| Dividend Receivable |
-- |
| Inventories |
3,242,883,021.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
86,043,757.72 |
| Total Current Assets |
9,469,759,323.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
139,591,833.33 |
| Investment Properties |
452,385,635.27 |
| Fixed Assetes |
1,880,271,457.63 |
| Under-construction Projects |
264,293,180.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
692,856,973.06 |
| R&D expenses |
133,336,496.10 |
| Goodwill |
1,987,774,628.39 |
| Long-Term Deferred and Prepaid Expenses |
29,144,360.73 |
| Deferred Income Tax Assets |
123,806,709.11 |
| Other Non-Current Assets |
218,298,999.17 |
| Sub-Total of Non-Current Assets |
6,021,956,287.18 |
| Total Assets |
15,491,715,610.53 |
| Short-Term Loans |
3,238,453,948.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
781,270,298.59 |
| Accounts Payable |
1,917,521,579.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,103,894.76 |
| Taxes Payable |
76,278,738.22 |
| Interest Payable |
-- |
| Dividend Payable |
468,422.13 |
| Other payables |
132,357,672.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,367,095,529.06 |
| Other Current Liabilities |
52,719,009.24 |
| Sub-Total of Current Liabilities |
8,038,095,445.80 |
| Long-term Loans |
953,255,341.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
97,013,946.54 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,277,579.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,606,534,818.92 |
| Total Liabilities |
9,644,630,264.72 |
| Paid-In Capital(Or Share Stock) |
1,598,616,721.00 |
| Capital Surplus |
2,666,729,107.20 |
| Surplus Reserve |
257,828,715.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,363,684,221.25 |
| Minority Stockholder's Interest |
-21,845,327.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,868,930,672.95 |
| Owner's Equity（Stockholder's Equity） |
5,847,085,345.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,491,715,610.53 |
